US · Healthcare · Medical Care Facilities
EPS came in at -0.30 against a street estimate of -0.31 — a beat of 3.2%.
Analysts rate Compass Pathways Plc a strong buy (11 buy, 0 hold, 0 sell out of 11) with an average price target of $23.75.
| Fund | Stake |
|---|---|
| Deep Track Capital, LP | 9.01% |
| RTW INVESTMENTS, LLC | 7.88% |
| Marshall Wace Asset Management Ltd | 2.99% |
| TANG CAPITAL MANAGEMENT LLC | 2.97% |
| ARK Investment Management LLC | 2.45% |
| Millennium Management LLC | 2.33% |
| GMT Capital Corp | 2.28% |
| Two Sigma Investments LLC | 1.91% |
| Document | Date |
|---|---|
| Reg FD disclosure · Q3 2026 | 2026-07-07 |
| Shareholder vote results · Q2 2026 | 2026-05-28 |
| Results announced · Q2 2026 | 2026-05-13 |
| Quarterly report · Q1 2026 | 2026-05-13 |
| Proxy statement · Q2 2026 | 2026-04-15 |
| Annual report FY2025 | 2026-03-24 |
| Results announced · Q1 2026 | 2026-03-24 |
| Quarterly report · Q3 2025 | 2025-11-04 |
Readable in the app.
Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Compass Pathways Plc — free to start.
Google PlayApp StoreData updated 2026-08-05.